Clinical Trial Update: Circulating Tumor Cells as Tools for Therapy Response in Nab-paclitaxel Treated Metastatic Pancreatic Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating circulating tumor cells as tools for monitoring therapy response in patients with metastatic pancreatic cancer treated with na…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Nab-paclitaxel (paclitaxel protein-bound)

Snippet

Sponsor: Helse Stavanger HF | Conditions: Metastatic Pancreatic Cancer | Phase 2 | Status: COMPLETED